Chieh-Ming (Ben) Hsu
FDA Accepts Outlook Therapeutics’ BLA for Ophthalmic Bevacizumab
Big Molecule Watch ·
Lupin Announces Approval of ENBREL Biosimilar in Canada
Big Molecule Watch ·
U.S. Senators Request PTO Action on Patent Thickets
Big Molecule Watch ·
Formycon AG Acquires Biosimilar Assets Ustekinumab and Ranibuzumab
Big Molecule Watch ·
Biosimilar Deal Watch: Formycon/ATHOS, Fresenius/mAbxience/Ivenix, and Intas/Axantia
Big Molecule Watch ·